The administration of the cannabinoid CB1 receptor antagonist AM-251 blocked the anxiolytic and sedative actions of benzodiazepines

被引：0
|
作者：
Navarro, D. V. [1 ]
Sanguino, E. [1 ]
Manzanares, J. [1 ]
机构：
[1] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2006年 / 16卷
关键词：
D O I：
10.1016/S0924-977X(06)70196-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [21] Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
    Sink, K. S.
    Segovia, K. N.
    Nunes, E. J.
    Collins, L. E.
    Vemuri, V. K.
    Thakur, G.
    Makriyannis, A.
    Salamone, J. D.
    [J]. PSYCHOPHARMACOLOGY, 2009, 206 (02) : 223 - 232
  • [22] Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats
    K. S. Sink
    K. N. Segovia
    E. J. Nunes
    L. E. Collins
    V. K. Vemuri
    G. Thakur
    A. Makriyannis
    J. D. Salamone
    [J]. Psychopharmacology, 2009, 206 : 223 - 232
  • [23] The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats
    Kozan, Ramazan
    Ayyildiz, Mustafa
    Agar, Erdal
    [J]. EPILEPSIA, 2009, 50 (07) : 1760 - 1767
  • [24] Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist
    Botanas, Chrislean Jun
    de la Pena, June Bryan
    de la Pena, Irene Joy
    Tampus, Reinholdgher
    Kim, Hee Jin
    Yoon, Seong Shoon
    Seo, Joung-Wook
    Jeong, Eun Ju
    Cheong, Jae Hoon
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 766 : 135 - 141
  • [25] Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia
    Ren, Y.
    Wang, J.
    Xu, P. B.
    Xu, Y. J.
    Miao, C. H.
    [J]. NEUROSCIENCE LETTERS, 2015, 584 : 287 - 291
  • [26] Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat
    Chambers, AP
    Sharkey, KA
    Koopmans, HS
    [J]. PHYSIOLOGY & BEHAVIOR, 2004, 82 (05) : 863 - 869
  • [27] Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion
    Liberato Costa da Veiga, Marco Aurelio
    Bloise, Flavia Fonseca
    Costa-e-Sousa, Ricardo Henrique
    Souza, Luana Lopes
    dos Santos Almeida, Norma Aparecida
    Oliveira, Karen Jesus
    Pazos-Moura, Carmen Cabanelas
    [J]. JOURNAL OF ENDOCRINOLOGY, 2008, 199 (02) : 235 - 242
  • [28] Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor
    Garcia, DE
    Brown, S
    Hille, B
    Mackie, K
    [J]. JOURNAL OF NEUROSCIENCE, 1998, 18 (08): : 2834 - 2841
  • [29] Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?
    Doggrell, SA
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (12) : 2141 - 2144
  • [30] Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251
    Vinklerová, J
    Nováková, J
    Sulcová, A
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (02) : 139 - 143
12345